Ismotic Related Published Studies
Well-designed clinical trials related to Ismotic (Isosorbide)
No recovery of cold complex regional pain syndrome after transdermal isosorbide dinitrate: a small controlled trial. [2009.09]
Addition of propranolol and isosorbide mononitrate to endoscopic variceal ligation does not reduce variceal rebleeding incidence. [2009.09]
Randomised placebo-controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour--clinical trial with analyses of efficacy and acceptability. The IMOP study. [2009.08]
The cost-effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. [2009.08]
Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial. [2009.08]
Efficacy of beta-adrenergic blocker plus 5-isosorbide mononitrate and endoscopic band ligation for prophylaxis of esophageal variceal rebleeding: a meta-analysis. [2009.05.07]
Propranolol, isosorbide mononitrate and endoscopic band ligation - alone or in varying combinations for the prevention of esophageal variceal rebleeding. [2009.05]
Cervical priming in the first trimester: morphological and biochemical effects of misoprostol and isosorbide mononitrate. [2009]
Isosorbide mononitrate versus alendronate for postmenopausal osteoporosis. [2008.12]
Isosorbide mononitrate versus alendronate for postmenopausal osteoporosis. [2008.09.20]
Outpatient cervical ripening with nitric oxide donor isosorbide mononitrate prior to induction of labor. [2008.04]
Pentaerythrityl tetranitrate and nitroglycerin, but not isosorbide mononitrate, prevent endothelial dysfunction induced by ischemia and reperfusion. [2007.09]
Evidence for the continued safety and tolerability of fixed-dose isosorbide dinitrate/hydralazine in patients with chronic heart failure (the extension to African-American Heart Failure Trial). [2007.08.15]
Nitric oxide donor isosorbide mononitrate for pre-induction cervical ripening at 41 weeks' gestation: A randomized controlled trial. [2007.08]
Pentaerythrityl Tetranitrate and Nitroglycerin, but not Isosorbide Mononitrate, Prevent Endothelial Dysfunction Induced by Ischemia and Reperfusion. [2007.07.19]
Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: results from A-HeFT. [2007.06]
Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial. [2007.04.03]
Once daily therapy with isosorbide-5-mononitrate causes endothelial dysfunction in humans: evidence of a free-radical-mediated mechanism. [2007.03.27]
Influence of systemically given placebo, trapidil and isosorbide dinitrate on norepinephrine-evoked hand vein constriction in healthy subjects. [2007]
Outpatient cervical ripening before first-trimester surgical abortion: a comparison between misoprostol and isosorbide mononitrate. [2007]
Induction of labor at term using isosorbide mononitrate simultaneously with dinoprostone compared to dinoprostone treatment alone: a randomized, controlled trial. [2006.12]
Comparison of endoscopic variceal ligation and nadolol plus isosorbide-5-mononitrate in the prevention of first variceal bleeding in cirrhotic patients. [2006.10]
Comparative study between nadolol and 5-isosorbide mononitrate vs. endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial. [2006.08.15]
Effectiveness of oral route isosorbide 5-mononitrate on peritoneal solute and fluid transports in CAPD patients. [2006.08]
A review of isosorbide dinitrate and hydralazine in the management of heart failure in black patients, with a focus on a new fixed-dose combination. [2006.05]
A randomized clinical trial of the effects of isosorbide mononitrate on bone formation and resorption in post-menopausal women: a pilot study. [2006.05]
The "PRIM" study: a randomized comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening before the induction of labor at term. [2006.04]
Intracervical application of the nitric oxide donor isosorbide dinitrate for induction of cervical ripening: a randomised controlled trial to determine clinical efficacy and safety prior to first trimester surgical evacuation of retained products of conception. [2005.12]
Randomized controlled trial of vaginal misoprostol versus vaginal misoprostol and isosorbide dinitrate for termination of pregnancy at 13-29 weeks. [2005.12]
Comparison of isosorbide mononitrate (Mono Mack) and misoprostol (Cytotec) for cervical ripening in the first trimester missed abortion. [2005.12]
Comparative effects of nicorandil with isosorbide mononitrate on cardiac sympathetic nerve activity and left ventricular function in patients with ischemic cardiomyopathy. [2005.09]
Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients. [2005.08]
Hemodynamic effects of sildenafil citrate and isosorbide mononitrate in men with coronary artery disease and erectile dysfunction. [2005.05]
Second trimester abortion using isosorbide mononitrate in addition to gemeprost compared with gemeprost alone: a double-blind randomized, placebo-controlled multicenter trial. [2005.03]
Well-designed clinical trials possibly related to Ismotic (Isosorbide)
A randomized, controlled trial of banding ligation plus drug therapy versus drug therapy alone in the prevention of esophageal variceal rebleeding. [2009.06]
Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial. [2009.04]
Topical anal fissure treatment: placebo-controlled study of mononitrate and trinitrate therapies. [2009.04]
Effect of nicorandil on proteinuria in well controlled hypertensive patients. [2009.03]
Clinical trial: a randomized controlled study on prevention of variceal rebleeding comparing nadolol + ligation vs. hepatic venous pressure gradient-guided pharmacological therapy. [2009.02.15]
Coronary vasomotor and blood flow responses to isoflavone-intact soya protein in subjects with coronary heart disease or risk factors for coronary heart disease. [2008.12]
Effect of PCI on quality of life in patients with stable coronary disease. [2008.08.14]
Prevention of recurrent esophageal variceal hemorrhage: review and current recommendations. [2007.11]
Double-blind, multicenter, active-controlled, randomized clinical trial to assess the safety and efficacy of orally administered nicorandil in patients with stable angina pectoris in china. [2007.06]
Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity and left ventricular remodeling in patients with first anterior acute myocardial infarction. [2007.02.13]
Lipid peroxidation is not increased in heart failure patients on modern pharmacological therapy. [2006.10.10]
Neurohumoral changes in patients with left ventricular dysfunction following acute myocardial infarction and the effect of nitrate therapy: a randomized, double-blind, placebo-controlled long-term study. [2006.10]
The effects of organic nitrates on osteoporosis: a randomized controlled trial [ISRCTN94484747]. [2006.04.26]
Use of antihypertension agents for the suppression of arterial pulse pressure waveforms in patients with intracranial aneurysms. [2006.04]
Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis. [2006.03]
Pharmacologic treatment of portal hypertension in the prevention of community-acquired spontaneous bacterial peritonitis. [2006.01]
Preservation of platelet responsiveness to nitroglycerine despite development of vascular nitrate tolerance. [2005.10]
[Trial study on DENG Tie-tao's coronary heart disease capsules in improving patients' quality of life.] [2005.09]
[Clinical study on "sini" decoction on treating stenocardia for coronary heart disease] [2005.08]
Effects of the long-term administration of nicorandil on vascular endothelial function and the progression of arteriosclerosis. [2005.07]
Nitroester drug's effects and their antagonistic effects against morphine on human sphincter of Oddi motility. [2005.04.21]
Effects of nicorandil on cardiac sympathetic nerve activity after reperfusion therapy in patients with first anterior acute myocardial infarction. [2005.03]
Myocardial protective effects of nicorandil during percutaneous coronary intervention in patients with unstable angina. [2005.03]
Long-term effectiveness of extended-release nitrate for the treatment of systolic hypertension. [2005.03]
[Effect of compound salvia injection on nitrate ester tolerance] [2005.01]
Efficacy and safety of molsidomine once-a-day in patients with stable angina pectoris. [2005.01]
Effects of a mononitrate, a beta1-blocker and a dihydropyridine calcium channel blocker on cardiovascular responsiveness to passive orthostasis: a placebo-controlled double-blind study in normotensive volunteers. [2005]
Other research related to Ismotic (Isosorbide)
Effects of fixed-dose isosorbide dinitrate/hydralazine on diastolic function and exercise capacity in hypertension-induced diastolic heart failure. [2009.09]
Comparison of exercise-rest-reinjection Tl-201 imaging and rest sublingual isosorbide dinitrate Tc-99m MIBI imaging for the assessment of myocardial viability. [2009.07]
Usefulness of Isosorbide Dinitrate and Hydralazine as add-on therapy in patients discharged for advanced decompensated heart failure. [2009.04.15]
Comparison of intracoronary adenosine and isosorbide dinitrate on no-reflow/slow flow during rotational atherectomy. [2009.04]
Effectiveness of hydralazine/isosorbide dinitrate in racial/ethnic subgroups with heart failure. [2009.03]
Incorporation of isosorbide into poly(butylene terephthalate) via solid-state polymerization. [2008.11]
Incorporation of Isosorbide into Poly(butylene terephthalate) via Solid-State Polymerization. [2008.10.07]
Nitric oxide-induced headache may arise from extracerebral arteries as judged from tolerance to isosorbide-5-mononitrate. [2008.09]
Head-up tilt table testing in syncope: safety and efficiency of isosorbide versus isoproterenol in pediatric population. [2008.09]
Fixed-dose isosorbide dinitrate-hydralazine: race-based cardiovascular medicine benefit or mirage? [2008.09]
Nitric oxide-induced headache may arise from extracerebral arteries as judged from tolerance to isosorbide-5-mononitrate. [2008.08]
Combined effect of liposomalization and addition of glycerol on the transdermal delivery of isosorbide 5-nitrate in rat skin. [2008.06.05]
Nitric oxide-induced headache may arise from extracerebral arteries as judged from tolerance to isosorbide-5-mononitrate. [2008.06.03]
Isosorbide mononitrate vaginal gel versus misoprostol vaginal gel versus Dilapan-S((R)) for cervical ripening before first trimester curettage. [2008.06]
Intracoronary administration of isosorbide dinitrate induced severely slow flow and transient ST-segment elevation. [2008.06]
Isosorbide dinitrate spray as therapeutic strategy for treatment of chronic venous ulcers. [2008.02]
Vasodilative effect of isosorbide dinitrate ointment in complex regional pain syndrome type 1. [2008.01]
Pharmacokinetic interaction of the direct renin inhibitor aliskiren with furosemide and extended-release isosorbide-5-mononitrate in healthy subjects. [2008.01]
Isosorbide mononitrate vaginal gel versus misoprostol vaginal gel versus Dilapan-S((R)) for cervical ripening before first trimester curettage. [2007.11.01]
Cost comparison analysis: pentaerythrithyl tetranitrate (PETN) and isosorbide dinitrate (ISDN) prescribed to diabetic patients in primary care practices in Germany. [2007.09]
A novel transdermal patch incorporating isosorbide dinitrate with bisoprolol: in vitro and in vivo characterization. [2007.06.07]
Isosorbide dinitrate-hydralazine improves outcomes in African Americans with heart failure. [2007.03]
Isosorbide mononitrate induces increased cervical expression of cyclooxygenase-2, but not of cyclooxygenase-1, at term. [2007.02]
Topical application of isosorbide dinitrate in patients with persistent constipation after pull-through surgery for Hirschsprung's disease. [2007.02]
Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure Trial. [2007.01.02]
Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study. [2007.01]
BiDil (isosorbide dinitrate and hydralazine): a new fixed-dose combination of two older medications for the treatment of heart failure in black patients. [2007.01]
Lack of Bioequivalence between Different Formulations of Isosorbide Dinitrate and Hydralazine and the Fixed-Dose Combination of Isosorbide Dinitrate/Hydralazine: The V-HeFT Paradox. [2007]
Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial. [2007]
Fixed combination isosorbide dinitrate-hydralazine for nitric-oxide-enhancing therapy in heart failure. [2006.12]
Efficacy and safety of controlled-release isosorbide-5-mononitrate in Japanese patients with stable effort angina pectoris. [2006.09]
IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour - clinical trial with analyses of efficacy, cost effectiveness and acceptability. [2006.07.25]
[Favourable results with local injections of botulinum-A toxin in patients with chronic isosorbide dinitrate ointment-resistant anal fissures] [2006.07.08]
Trapidil is as effective as isosorbide-dinitrate for treating stable angina pectoris: a multinational, multicenter, double-blind, randomized study. [2006.04]
Effect of intermittent administration of sustained release isosorbide dinitrate (sr-ISDN) in rats with pressure-overload heart. [2006.03]
The effect of intermittent administration of sustained release isosorbide dinitrate (sr-ISDN) in rats with volume overload heart. [2006.01]
Antidiuretic hormone and osmolality in isosorbide therapy and glycerol test. [2006]
Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure. [2006]
Cost-effectiveness of fixed-dose combination of isosorbide dinitrate and hydralazine therapy for blacks with heart failure. [2005.12.13]
Perioperative sublingual isosorbide dinitrate for the prevention of cardiac complications in cardiac patients undergoing noncardiac surgery. [2005.11]
|
